Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Microorganisms in the gut influence how the body responds to common cancer treatments, including immunotherapy.
Compared with men, women had a 34% greater likelihood of adverse events, especially if they received immunotherapy.
New insights into why men fail to mount as powerful an immune response to many cancers as women do.
Single-cell sequencing tech enables deep dive into mysterious results, sets stage for future improvements.
The largest peer-reviewed study of the Pfizer-BioNTech COVID vaccine in cancer patients finds no more, and no different, side effects.
Keytruda can activate T cells that harbor latent HIV, a possible step toward a functional cure.
The first two people treated with the “living drug” remained cancer-free for a decade and can be considered cured.
Providers who treat smokers with lung cancer should offer support to help them quit.
Allergy meds were linked to longer survival among cancer patients treated with immune checkpoint inhibitors.
Low fiber consumption and use of probiotics were linked to poorer response to checkpoint inhibitors for melanoma patients.
Targeted therapies are available for eight tumor mutations, highlighting the importance of genomic testing.
The antibody-drug conjugate Tivdak led to remission in 24% of cervical cancer patients.
Many older people have biomarkers indicative of a strong response to checkpoint inhibitors.
The immune system has a natural ability to shut down cells that grow out of control, but cancer has many ways to get around these defenses.
Early treatment is linked to a smaller viral reservoir, but blocking IL-10 and PD-1 might control the virus in those with chronic infection.
Some people with blood cancers, however, may not be as well protected.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.